FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Exela Pharma Sciences Diclofenac Sodium and Misoprostol Delayed Recall

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0

Exela Pharma Sciences LLC · Lenoir, NC

Risk level
Class II
Reported by FDA
May 30, 2018
Recall ID
D-0826-2018
Check your lot numberHow we source this data

Summary

Exela Pharma Sciences recalled Diclofenac Sodium and Misoprostol Delayed starting Apr 20, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0826-2018 on May 30, 2018. Reason: Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets. Status: Terminated.

Why it was recalled

Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.

Product description

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.

Lot numbers, UPCs & expiration codes

Lot: GH70154, Exp 12/18

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0826-2018
Classification
Class II
Status
Terminated
Recall initiated
Apr 20, 2018
FDA report date
May 30, 2018
Quantity
5256 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Exela Pharma Sciences LLC

Original FDA data

Every field from FDA enforcement report D-0826-2018, exactly as published.

Show all FDA fields
City
Lenoir
State
NC
Status
Terminated
Country
United States
Event ID
79969
Address
1245 Blowing Rock Blvd
Code information
Lot: GH70154, Exp 12/18
Postal code
28645-3618
Report date
May 30, 2018
Product type
Drugs
Recall number
D-0826-2018
Classification
Class II
Recalling firm
Exela Pharma Sciences LLC
Product quantity
5256 bottles
Termination date
Jun 4, 2020
Reason for recall
Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Apr 20, 2018
Initial firm notification
Letter
Center classification date
May 22, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0826-2018, published May 30, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls